INSULIN HUMAN, ISOPHANE (NPH) 100 UI/ml, 3ml, pref. pen N

STD DINJINSHI3APN

Valid Article

Former Code(s): DINJZFR0198 DINJINSH3API
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
A018006 - Hypodermic needles pen injectors
European Medical Device Nomenclature (EMDN) is the nomenclature of use by manufacturers when registering their medical devices in the EUDAMED database. EMDN is characterised by its alphanumeric structure that is established in a seven-level hierarchical tree.
A10AC01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

INSULIN ISOPHANE (NPH) human, pre-filled pen

Image

Full Name

Insulatard InnoL® or Insulatard FlexPen®

Therapeutic Action

Pancreatic hormone, antidiabetic

Intermediate-acting isophane human insulin.

Isophane insulin is a mixture of regular human insulin with NPH (Neutral Protamine Hagedornis) to delay absorption and prolong the duration of action.

Action profile:

  • onset of action: 1 - 2 hours
  • peak action: 4 - 12 hours
  • duration of action: 14-18 hours

These action profiles are based on subcutaneous injections and are approximate. They depend on the dose injected, the type and brand of insulin, and can vary significantly from one patient to another.

See Preliminary remarks on Insulins.

Indications

Diabetes

Insulin to cover basal insulin requirements.

Insulin pre-filled pens are the preferred option for the patient self-administration (and OPD use).

Instructions for use

A portable, hand-held device, typically in the form of a large pen, prefilled with a pharmaceutical agent and intended to be used by a patient to subcutaneously inject a dose of the pharmaceutical via a replaceable needle. The device typically includes a dial for dosing and is discarded when the pharmaceutical is exhausted and is therefore used over a short period (single-use).

Must be given as deep SC injection only.

Before using insulin for the first time, allow it to reach room temperature for 1 or 2 hours (cold insulin is more painful).

Preparation for administration

  • Wash hands.
  • Check the pen label (type and strength of insulin, expiry date) and inspect the solution (it should be opaque, white and aqueous).
  • Stir the insulin by gently rolling the pen between the palms of the hands. Do not shake the pen.
  • Remove the cap from the pen.
  • Wipe the pen tip (rubber seal) with a disinfectant.
  • Attach a pen needle to the pen after removing the protective seal of the needle. Push the needle straight onto the pen and screw it on tightly.
  • Remove the outer cap of the needle and save it (you will need it to remove the needle after the injection).
  • Remove the inner cap of the needle.
  • Remove air from the pen. Pointing the needle upward select one or two units on the pen, and gently tap the pen to move air bubbles to the top of the pen.
  • Press the injection button. A drop of insulin should appear on the tip of the needle. If no drop appears, change the needle and repeat this step.
  • Select the correct dose on the pen by turning the dose selector to the required number of units.

How to administer SC insulin

  • Insulin can be injected into the abdomen (two fingers away from the belly button), upper arm, buttocks, hips, buttocks, or the front or side of the thigh.
  • repeatedly injecting insulin in the same area can cause lumps, swelling and thickened skin, which may interfere with proper absorption of the insulin. See the picture below on “rotating” injection sites.
  • Do not inject insulin into areas with wounds or bruising.
  • Clean the chosen injection site with soap and water. Allow to dry.
  • Pinch the skin.
  • Keep the pen straight at a 90-degree angle to the skin and insert the needle with one quick motion.
  • Press the injection button with the thumb to inject the dose of insulin. Wait for 10 seconds before releasing the button and removing the needle from the skin.
  • Apply gentle pressure on the injection site with a finger for 5-10 seconds to prevent insulin from leaking out.
  • Remove the needle from the pen by replacing the outer needle cap on and unscrewing it. Leaving the needle on the pen can result in leakage or air bubbles.
  • Dispose of the needle safely in a sharps container.
  • After each injection, replace the cap on the pen to protect it from light.

Education of patients

Arrange multiple counselling sessions to assess whether the patient is ready to begin self-injecting and understands the risks and management of hypoglycaemia, the use of the pre-filled pen (including insulin units), the proper injection technique, insulin storage, and waste management. If possible, involve the family or caregivers and provide an information leaflet adapted to the local context. Contact your OC referent for more details.

Image

Precautions for Use

Depending on the model, the number of units contained in a pen may vary. The pen is designed with a safety stop, so it is not possible to dial more units than what remains in the pen.

If the remaining units in the pen are insufficient for the full dose, inject the available amount with the current pen and use a new pen to administer the remaining dose (select.the missing amount).

Once the pen is empty, it should be discarded.

Switching the patient to a different insulin type or brand (manufacturer) is not recommended.

The manufacturer is identified by a letter at the end of the code and the label: N = Novo Nordisk, S = Sanofi, L = Lilly.

Storage

  • Unopened pens: store in the refrigerator between 2ºC and 8ºC - Protect from sunlight
  • Pens in use Insulatard InnoL® or Insulatard FlexPen®: may be kept for up to 6 weeks at temperature not exceeding 30ªC.
  • Do not freeze. Discard any pen that has been frozen.
  • Do not store the pen with a needle attached.

(Cf Introduction: Thermosensitive products)